Hem › Kronisk lymfatisk leukemi › Kalifornien › San Diego
Kliniska studier för Kronisk lymfatisk leukemi i San Diego, CA
10 studier för Kronisk lymfatisk leukemi söker deltagare vid platser i och runt San Diego (inom ca 30 miles). Öppna en studie för att se vem som kan delta och hur du kontaktar studieteamet.
Officiell studietext (engelska)
Rekryterar du till en studie? Visa den högst upp på sidan – $99 i 30 dagar →
A Dose-Escalation and Expansion Study of Tacabrutideg (BGB-16673) in Participants With B-Cell Malignancies
RekryterarFas 1/2
- University of California San Diego (Ucsd) Moores Cancer Center, La Jolla · 11 mi bort
Testing the Addition of Anti-Cancer Drug Sonrotoclax, to the Standard Treatment Zanubrutinib, for Previously Untreated CLL/SLL
RekryterarFas 3
- Kaiser Permanente-San Diego Zion, San Diego
Testing Early Treatment for Patients With High-Risk Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Leukemia (SLL), EVOLVE CLL/SLL Study
RekryterarFas 3
- Kaiser Permanente-San Diego Zion, San Diego
A Study to Evaluate Safety, PK, PD and Efficacy of AZD5492, a T Cell-engaging Antibody Targeting CD20 in Subjects With R/R B-Cell Malignancies.
RekryterarFas 1/2
- Research Site, La Jolla · 11 mi bort
A Study of Tacabrutideg (BGB-16673) Compared to Investigator's Choice in Participants With Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma Previously Exposed to Both Bruton Tyrosine Kinase (BTK) and B-cell Leukemia/Lymphoma 2 Protein (BCL2) Inhibitors
RekryterarFas 3
- Scripps Prebys Cancer Center, San Diego
A Study to Investigate Progression-Free Survival With Sonrotoclax Plus Obinutuzumab Or Sonrotoclax Plus Rituximab Compared With Venetoclax Plus Rituximab Treatment In Patients With Relapsed and/or Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CELESTIAL-RRCLL)
RekryterarFas 3
- Scripps Prebys Cancer Center, San Diego
A Study to Evaluate the Safety and Efficacy of Tacabrutideg (BGB-16673) Compared to Pirtobrutinib in Adults With Relapsed/Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
RekryterarFas 3
- University of California San Diego (Ucsd) Moores Cancer Center, La Jolla · 11 mi bort
A Study of Nemtabrutinib (MK-1026) Versus Comparator (Investigator's Choice of Ibrutinib or Acalabrutinib) in First Line (1L) Chronic Lymphocytic Leukemia (CLL)/ Small Lymphocytic Lymphoma (SLL) (MK-1026-011/BELLWAVE-011)
RekryterarFas 3
- Moores Cancer Center ( Site 0003), La Jolla · 11 mi bort
A Study of NX-5948 in Adults With CLL/SLL Previously Treated With a Bruton's Tyrosine Kinase Inhibitor and a B-cell Lymphoma-2 Inhibitor (DAYBreak CLL-201)
RekryterarFas 2
- Scripps Health, San Diego
Study to Assess Change in Disease Activity and Adverse Events of Oral Venetoclax With Intravenous (IV) Obinutuzumab in Adult Participants With Recurring Chronic Lymphocytic Leukemia (CLL)
RekryterarFas 2
- Moores Cancer Center at UC San Diego /ID# 230157, La Jolla · 11 mi bort
Kronisk lymfatisk leukemi-studier i andra städer
- Boston, MA31 studier
- Columbus, OH28 studier
- Durham, NC27 studier
- Washington, DC22 studier
- Seattle, WA20 studier
- Rochester, MN18 studier
- New York City, NY18 studier
- Houston, TX17 studier
- Baldwin Park, CA16 studier
- Milwaukee, WI15 studier
- Chicago, IL14 studier
- Cincinnati, OH14 studier
Andra studier i San Diego
- Icke-småcellig lungcancer48 studier
- Bröstcancer41 studier
- Cancer (alla typer)32 studier
- Prostatacancer31 studier
- Metastaserande cancer30 studier
- Kolorektal cancer25 studier
- Äggstockscancer24 studier
- Bukspottkörtelcancer24 studier
- Lungcancer23 studier
- Övervikt23 studier
- Hjärtsvikt23 studier
- Depression21 studier
Från ClinicalTrials.gov, data hämtad 6 okt. 2026. Varje studie har egna kvalifikationskrav; studieteamet avgör vem som kan delta.